Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
JAMA ; 268(13): 1683; author reply 1684-5, 1992 Oct 07.
Article in English | MEDLINE | ID: mdl-1527873
2.
Int J Radiat Oncol Biol Phys ; 11(3): 567-74, 1985 Mar.
Article in English | MEDLINE | ID: mdl-3972666

ABSTRACT

Since hypoxic cells rely heavily on glucose metabolism for energy, 2-deoxy-D-glucose (2-DG), an inhibitor of anaerobic glycolysis, would be expected to increase tumor cell killing by heat and thus enhance the effect of concurrent radiation. In order to test this hypothesis two types of BALB/c mouse tumors, one induced by subcutaneous injection of 10(6) herpes virus Type 2-transformed (H238) cells and the other by injection of 1.6 X 10(5) 1,2-dimethylhydrazine-transformed (#51) cells in the right thigh, were subjected to radiation, 2-DG, and heat used singly and in various combinations. Control mice were injected with saline. Three to four weeks after inoculation the mice were assigned to one of eight treatment groups (28 mice/group) so that average tumor volume/group before treatment would be equivalent. A single 2000 rad dose of radiation 3 hr prior to heat and 2-DG injected intraperitoneally at 1 g/kg 30 min before heating were given to some of the groups. Localized heat at 43.5 +/- 0.1 degrees C for 30 min, when used, was administered by means of a water bath. Rectal temperatures were kept below 39 degrees C, whereas intratumor temperatures reached a maximum of 42 degrees C. After treatment, tumor volume, mouse weight, and mortality were noted twice a week for four weeks. In both tumor models, mice receiving radiation plus heat, and radiation plus heat plus 2-DG, had significantly smaller tumors over the entire 4 to 28 day range after treatment than saline-injected control mice. In addition, in the H238 tumor model, addition of 2-DG to treatment with radiation and heat resulted in significantly smaller tumors at 25 days. 2-DG alone or in combination with heat (without radiation) resulted in significantly smaller H238 cell-induced tumors at day 28 post-treatment when compared to the saline controls. The H238 tumor-bearing mice experienced a significant (4.7%) loss in total body weight after heating. It could be that heating trauma produced dehydration and possibly also decreased caloric intake to an extent which could be measured in weight loss. This observation, however, was not made in the heated mice in the #51 tumor model.


Subject(s)
Deoxy Sugars/therapeutic use , Deoxyglucose/therapeutic use , Hyperthermia, Induced , Neoplasms, Experimental/therapy , Animals , Combined Modality Therapy , Male , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , Neoplasms, Experimental/drug therapy , Neoplasms, Experimental/radiotherapy
3.
Oncology ; 42(6): 391-8, 1985.
Article in English | MEDLINE | ID: mdl-4069554

ABSTRACT

Radiation (XRT), hyperthermia, 2-deoxy-D-glucose (2DG), and Corynebacterium parvum were given in various combinations to BALB/c mice injected with herpes virus type 2-transformed (H238) cells. Addition of heat significantly increased the antitumor effects of XRT, and the combination of XRT + 2DG + heat resulted in the highest incidence of complete tumor regression. Enhanced activity of phytohemagglutinin-responsive T lymphocytes and natural killer cells capable of killing YAC-1 tumor cells was noted in some of the treatment groups while tumor volume was similar for all of the groups. This enhancement was most likely to be achieved when heat was included as part of the treatment protocol.


Subject(s)
Bacterial Vaccines/therapeutic use , Deoxy Sugars/therapeutic use , Deoxyglucose/therapeutic use , Hot Temperature/therapeutic use , Neoplasms/immunology , Propionibacterium acnes/immunology , Animals , Body Temperature , Body Weight , Cell Line , Combined Modality Therapy , Killer Cells, Natural/immunology , Lymphocyte Activation , Male , Mice , Mice, Inbred BALB C , Neoplasms/pathology , Neoplasms/radiotherapy , Neoplasms/therapy , Organ Size , Phytohemagglutinins/pharmacology , Spleen/drug effects , Spleen/immunology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...